Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoglycemia | 3 | 2025 | 64 | 2.280 |
Why?
|
| Pregnancy | 26 | 2026 | 2374 | 2.210 |
Why?
|
| Diabetes, Gestational | 4 | 2023 | 142 | 2.080 |
Why?
|
| Pre-Eclampsia | 4 | 2024 | 72 | 1.770 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2025 | 70 | 1.520 |
Why?
|
| Cesarean Section | 3 | 2025 | 100 | 1.460 |
Why?
|
| Prediabetic State | 2 | 2022 | 54 | 1.390 |
Why?
|
| Pregnancy Complications | 3 | 2025 | 385 | 1.250 |
Why?
|
| Pregnancy Outcome | 7 | 2023 | 197 | 1.180 |
Why?
|
| Glucocorticoids | 2 | 2025 | 189 | 1.100 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 630 | 1.030 |
Why?
|
| Infant, Newborn | 9 | 2025 | 1422 | 0.980 |
Why?
|
| Betamethasone | 1 | 2025 | 6 | 0.920 |
Why?
|
| Pulmonary Edema | 1 | 2025 | 29 | 0.900 |
Why?
|
| Obstetric Labor Complications | 2 | 2022 | 23 | 0.880 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 731 | 0.870 |
Why?
|
| Microbiota | 2 | 2026 | 168 | 0.860 |
Why?
|
| Female | 28 | 2026 | 34031 | 0.850 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 48 | 0.850 |
Why?
|
| Retrospective Studies | 14 | 2025 | 6865 | 0.840 |
Why?
|
| Labor, Obstetric | 2 | 2014 | 35 | 0.790 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2023 | 62 | 0.760 |
Why?
|
| Perinatal Death | 1 | 2022 | 4 | 0.730 |
Why?
|
| Lacerations | 1 | 2022 | 15 | 0.720 |
Why?
|
| Parturition | 4 | 2023 | 53 | 0.710 |
Why?
|
| Fecal Incontinence | 1 | 2022 | 32 | 0.710 |
Why?
|
| Pregnancy in Diabetics | 1 | 2021 | 12 | 0.700 |
Why?
|
| Colostrum | 1 | 2021 | 6 | 0.700 |
Why?
|
| Insulins | 1 | 2021 | 15 | 0.700 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 39 | 0.690 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 50 | 0.670 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 90 | 0.660 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 170 | 0.650 |
Why?
|
| Premature Birth | 1 | 2022 | 113 | 0.640 |
Why?
|
| Asthma | 1 | 2025 | 483 | 0.640 |
Why?
|
| Blood Glucose | 4 | 2023 | 497 | 0.630 |
Why?
|
| Humans | 29 | 2026 | 65142 | 0.600 |
Why?
|
| Labor, Induced | 2 | 2020 | 26 | 0.530 |
Why?
|
| Risk Factors | 6 | 2025 | 5430 | 0.520 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 21 | 0.520 |
Why?
|
| Trial of Labor | 1 | 2017 | 7 | 0.510 |
Why?
|
| Hydroxyprogesterones | 1 | 2016 | 5 | 0.500 |
Why?
|
| Adolescent Health | 1 | 2017 | 13 | 0.500 |
Why?
|
| Cerclage, Cervical | 1 | 2016 | 4 | 0.500 |
Why?
|
| Pregnancy in Adolescence | 1 | 2017 | 21 | 0.500 |
Why?
|
| Obstetric Labor, Premature | 1 | 2016 | 31 | 0.490 |
Why?
|
| Hypertension | 1 | 2022 | 612 | 0.490 |
Why?
|
| Obesity | 2 | 2021 | 1273 | 0.450 |
Why?
|
| Adolescent Behavior | 1 | 2017 | 194 | 0.450 |
Why?
|
| Adult | 12 | 2026 | 17359 | 0.440 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 13 | 0.420 |
Why?
|
| Parity | 1 | 2014 | 71 | 0.410 |
Why?
|
| Birth Weight | 1 | 2014 | 83 | 0.410 |
Why?
|
| Pregnancy, Twin | 1 | 2013 | 7 | 0.400 |
Why?
|
| Gestational Age | 2 | 2025 | 193 | 0.370 |
Why?
|
| Umbilical Arteries | 2 | 2024 | 10 | 0.350 |
Why?
|
| Cholagogues and Choleretics | 1 | 2010 | 5 | 0.330 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2010 | 7 | 0.330 |
Why?
|
| Prednisone | 1 | 2010 | 83 | 0.320 |
Why?
|
| Hypoglycemic Agents | 2 | 2023 | 225 | 0.320 |
Why?
|
| Young Adult | 5 | 2026 | 4812 | 0.300 |
Why?
|
| Insulin | 2 | 2023 | 695 | 0.290 |
Why?
|
| Adolescent | 4 | 2023 | 6306 | 0.280 |
Why?
|
| Vagina | 1 | 2026 | 87 | 0.230 |
Why?
|
| Abruptio Placentae | 1 | 2024 | 2 | 0.220 |
Why?
|
| Blood Gas Analysis | 1 | 2024 | 34 | 0.210 |
Why?
|
| Fetal Blood | 1 | 2024 | 73 | 0.210 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2025 | 100 | 0.210 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2026 | 110 | 0.210 |
Why?
|
| Logistic Models | 2 | 2024 | 1270 | 0.200 |
Why?
|
| Infant, Premature | 1 | 2025 | 199 | 0.190 |
Why?
|
| Infusions, Intravenous | 1 | 2023 | 175 | 0.190 |
Why?
|
| Informed Consent | 1 | 2023 | 141 | 0.190 |
Why?
|
| Stillbirth | 1 | 2022 | 18 | 0.180 |
Why?
|
| Anal Canal | 1 | 2022 | 38 | 0.180 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 11 | 0.180 |
Why?
|
| Delivery, Obstetric | 1 | 2022 | 59 | 0.170 |
Why?
|
| Incidence | 1 | 2025 | 1419 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2021 | 95 | 0.170 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2021 | 38 | 0.170 |
Why?
|
| Preconception Care | 1 | 2021 | 23 | 0.170 |
Why?
|
| Cervical Ripening | 1 | 2020 | 11 | 0.160 |
Why?
|
| Oxytocin | 2 | 2020 | 44 | 0.160 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 114 | 0.160 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2020 | 36 | 0.160 |
Why?
|
| Glucose | 1 | 2023 | 476 | 0.160 |
Why?
|
| Prevalence | 2 | 2022 | 1445 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 2704 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2021 | 166 | 0.140 |
Why?
|
| Infant | 1 | 2023 | 1693 | 0.140 |
Why?
|
| Counseling | 1 | 2021 | 375 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2017 | 27 | 0.130 |
Why?
|
| Amniotomy | 1 | 2017 | 2 | 0.130 |
Why?
|
| Family Planning Services | 1 | 2017 | 21 | 0.130 |
Why?
|
| Indomethacin | 1 | 2016 | 23 | 0.120 |
Why?
|
| Prenatal Care | 1 | 2017 | 169 | 0.110 |
Why?
|
| Infant, Low Birth Weight | 1 | 2014 | 59 | 0.100 |
Why?
|
| Maternal Age | 1 | 2013 | 33 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2017 | 2102 | 0.090 |
Why?
|
| Hydronephrosis | 1 | 2012 | 11 | 0.090 |
Why?
|
| Male | 3 | 2025 | 31056 | 0.090 |
Why?
|
| Child | 1 | 2021 | 4612 | 0.080 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2010 | 16 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2016 | 2619 | 0.080 |
Why?
|
| Kidney | 1 | 2012 | 451 | 0.080 |
Why?
|
| Middle Aged | 2 | 2024 | 18273 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 3762 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2026 | 95 | 0.060 |
Why?
|
| Interleukin-4 | 1 | 2026 | 147 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2026 | 105 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2026 | 99 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2026 | 323 | 0.050 |
Why?
|
| Saliva | 1 | 2024 | 100 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2026 | 574 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2026 | 1141 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 325 | 0.050 |
Why?
|
| Masks | 1 | 2022 | 20 | 0.050 |
Why?
|
| Diet | 1 | 2026 | 536 | 0.040 |
Why?
|
| Cytokines | 1 | 2026 | 952 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 266 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 110 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 162 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 740 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 754 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2021 | 175 | 0.040 |
Why?
|
| Mothers | 1 | 2022 | 281 | 0.040 |
Why?
|
| Massachusetts | 1 | 2024 | 2145 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 1392 | 0.030 |
Why?
|
| Heart Failure | 1 | 2021 | 957 | 0.020 |
Why?
|
| Stroke | 1 | 2021 | 1211 | 0.020 |
Why?
|
| Connecticut | 1 | 2012 | 90 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 173 | 0.020 |
Why?
|
| United States | 1 | 2023 | 8098 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 14963 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1698 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 1785 | 0.020 |
Why?
|